Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Combination Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Combination Agreement

Entities:

GlaxoSmithKline plc; ID Biomedical Corp.; UBS Securities LLC

Date:

2005

Size:

240KB total

Price:

$71

ID:

#1218658

 

 

► Miscellany ► Agreements ► Misc. Agreements ► Other ► Combination Agreements
► Financial
► Biotech & Drugs ► Pharmaceutical Preparations
► Biotech & Drugs ► Biological Products

 

 

Start of Preview


 

COMBINATION AGREEMENT

 

AMONG

 

GLAXOSMITHKLINE plc,

 

GLAXOSMITHKLINE INC.,

 

AND

 

ID BIOMEDICAL CORPORATION

 

 

AS OF
SEPTEMBER 7, 2005

 



 

TABLE OF CONTENTS

 

ARTICLE 1

INTERPRETATION

 

 

 

 

1.1

Definitions

 

1.2

Interpretation Not Affected by Headings, etc

 

1.3

Rules of Construction

 

1.4

Material

 

1.5

Disclosure in Writing

 

1.6

Date For Any Action

 

1.7

Schedules

 

 

 

 

ARTICLE 2

THE ARRANGEMENT

 

 

 

 

2.1

Implementation Steps by the Company

 

2.2

Implementation Steps by GSK

 

2.3

Interim Order

 

2.4

Plan of Arrangement

 

2.5

Circular

 

2.6

Preparation of Filings

 

 

 

 

ARTICLE 3

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

 

 

 

3.1

Organization and Standing

 

3.2

Capitalization

 

3.3

Authority and No Conflicts

 

3.4

Consents; Approvals

 

3.5

No Defaults

 

3.6

Absence of Certain Changes or Events

 

3.7

Employment Matters

 

3.8

Reports; Financial Statements

 

3.9

Contracts

 

3.10

Litigation

 

3.11

Environmental

 

3.12

Tax Matters

 

3.13

Pension and Employee Benefits

 

3.14

Foreign Private Issuer

 

 

i



 

3.15

Compliance with Laws; Permits

 

3.16

Restrictions on Business Activities

 

3.17

Intellectual Property

 

3.18

Insurance

 

3.19

Property

 

3.20

Regulatory Matters

 

3.21

Opinion of Financial Advisor

 

3.22

Brokerage and Finders Fees

 

3.23

Rights Plan

 

3.24

Material Customers

 

3.25

Books and Records

 

3.26

Disclosure

 

3.27

Management Controls

 

 

 

 

ARTICLE 4

REPRESENTATIONS AND WARRANTIES OF GSK AND PARENT

 

 

 

 

4.1

Corporate Organization

 

4.2

Authority and No Conflicts

 

4.3

Consents; Approvals

 

4.4

Parent Approval

 

4.5

GSK Approval

 

4.6

No Vote Required

 

 

 

 

ARTICLE 5

COVENANTS AND AGREEMENTS

 

 

 

 

5.1

Covenants of the Company

 

5.2

Covenants of GSK and Parent

 

5.3

Access to Information

 

5.4

Indemnification

 

5.5

Covenants Regarding Non-Solicitation

 

5.6

Right to Accept a Superior Proposal

 

5.7

Employee Benefits

 

5.8

Pre-Acquisition Reorganizations

 

 

ii



 

5.9

Proxies Received and Dissent Notices

 

5.10

Closing Matters

 

5.11

Privacy Matters

 

 

 

 

ARTICLE 6

CONDITIONS

 

 

 

 

6.1

Mutual Conditions

 

6.2

Additional Conditions to the Obligations of GSK and Parent

 

6.3

Additional Conditions to the Obligations of the Company

 

6.4

Satisfaction of Conditions

 

 

 

 

ARTICLE 7

AMENDMENT AND TERMINATION

 

 

 

 

7.1

Amendment

 

7.2

Termination

 

7.3

Effect of Termination

 

7.4

Termination Fee

 

7.5

Effect of Termination Fee Payment

 

 

 

 

ARTICLE 8

GENERAL

 

 

 

 

8.1

Investigation

 

8.2

Non-Survival of Warranties, Covenants and Agreements

 

8.3